88 related articles for article (PubMed ID: 17324536)
1. Enhancing the tolerance of poly(isobutylcyanoacrylate) nanoparticles with a modular surface design.
Chauvierre C; Leclerc L; Labarre D; Appel M; Marden MC; Couvreur P; Vauthier C
Int J Pharm; 2007 Jun; 338(1-2):327-32. PubMed ID: 17324536
[TBL] [Abstract][Full Text] [Related]
2. Surface pressure-area isotherms of mixed cyclosporin-poly(isobutylcyanoacrylate) monolayers spread at the air/water interface.
Miñones J; Yebra-Pimentel E; Conde O; Iribarnegaray E; Casas Parada M; Vila Jato JL; Seijo B
J Pharm Sci; 1995 Apr; 84(4):508-11. PubMed ID: 7629746
[TBL] [Abstract][Full Text] [Related]
3. Characterization of fluorescent poly(isobutylcyanoacrylate) nanoparticles obtained by copolymerization of a fluorescent probe during Redox Radical Emulsion Polymerization (RREP).
Zandanel C; Vauthier C
Eur J Pharm Biopharm; 2012 Sep; 82(1):66-75. PubMed ID: 22634238
[TBL] [Abstract][Full Text] [Related]
4. Configuration of bovine serum albumin adsorbed on polymer particles with grafted dextran corona.
Vauthier C; Lindner P; Cabane B
Colloids Surf B Biointerfaces; 2009 Mar; 69(2):207-15. PubMed ID: 19135340
[TBL] [Abstract][Full Text] [Related]
5. Properties of polysaccharides grafted on nanoparticles investigated by EPR.
Bertholon I; Hommel H; Labarre D; Vauthier C
Langmuir; 2006 Jun; 22(12):5485-90. PubMed ID: 16732681
[TBL] [Abstract][Full Text] [Related]
6. Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide.
Bertholon I; Vauthier C; Labarre D
Pharm Res; 2006 Jun; 23(6):1313-23. PubMed ID: 16715369
[TBL] [Abstract][Full Text] [Related]
7. Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles.
Peracchia MT; Vauthier C; Passirani C; Couvreur P; Labarre D
Life Sci; 1997; 61(7):749-61. PubMed ID: 9252249
[TBL] [Abstract][Full Text] [Related]
8. Cell line-dependent cytotoxicity of poly(isobutylcyanoacrylate) nanoparticles coated with chitosan and thiolated chitosan: Insights from cultured human epithelial HeLa, Caco2/TC7 and HT-29/MTX cells.
Pradines B; Lievin-Le Moal V; Vauthier C; Ponchel G; Loiseau PM; Bouchemal K
Int J Pharm; 2015 Aug; 491(1-2):17-20. PubMed ID: 26051544
[TBL] [Abstract][Full Text] [Related]
9. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
[TBL] [Abstract][Full Text] [Related]
10. Novel composite core-shell nanoparticles as busulfan carriers.
Layre A; Couvreur P; Chacun H; Richard J; Passirani C; Requier D; Benoit JP; Gref R
J Control Release; 2006 Apr; 111(3):271-80. PubMed ID: 16488504
[TBL] [Abstract][Full Text] [Related]
11. Tuning complement activation and pathway through controlled molecular architecture of dextran chains in nanoparticle corona.
Coty JB; Eleamen Oliveira E; Vauthier C
Int J Pharm; 2017 Nov; 532(2):769-778. PubMed ID: 28450168
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice.
Nakada Y; Fattal E; Foulquier M; Couvreur P
Pharm Res; 1996 Jan; 13(1):38-43. PubMed ID: 8668676
[TBL] [Abstract][Full Text] [Related]
13. Artificial oxygen carrier based on polysaccharides-poly(alkylcyanoacrylates) nanoparticle templates.
Chauvierre C; Manchanda R; Labarre D; Vauthier C; Marden MC; Leclerc L
Biomaterials; 2010 Aug; 31(23):6069-74. PubMed ID: 20488532
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity and cellular uptake of newly synthesized fucoidan-coated nanoparticles.
Lira MC; Santos-Magalhães NS; Nicolas V; Marsaud V; Silva MP; Ponchel G; Vauthier C
Eur J Pharm Biopharm; 2011 Sep; 79(1):162-70. PubMed ID: 21349331
[TBL] [Abstract][Full Text] [Related]
15. Effect of polymer grafting density on silica nanoparticle toxicity.
Lin IC; Liang M; Liu TY; Jia Z; Monteiro MJ; Toth I
Bioorg Med Chem; 2012 Dec; 20(23):6862-9. PubMed ID: 23072957
[TBL] [Abstract][Full Text] [Related]
16. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush.
Labarre D; Vauthier C; Chauvierre C; Petri B; Müller R; Chehimi MM
Biomaterials; 2005 Aug; 26(24):5075-84. PubMed ID: 15769543
[TBL] [Abstract][Full Text] [Related]
17. A new generation of polymer nanoparticles for drug delivery.
Chauvierre C; Vauthier C; Labarre D; Couvreur P; Marden MC; Leclerc L
Cell Mol Biol (Noisy-le-grand); 2004 May; 50(3):233-9. PubMed ID: 15209344
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of poly(isobutylcyanoacrylate) nanoparticles for mucoadhesive ocular drug delivery. I. Effect of formulation variables on physicochemical characteristics of nanoparticles.
Das SK; Tucker IG; Hill DJ; Ganguly N
Pharm Res; 1995 Apr; 12(4):534-40. PubMed ID: 7596988
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of Poly(Alkyl Cyanoacrylate) Nanoparticles.
Sulheim E; Iversen TG; To Nakstad V; Klinkenberg G; Sletta H; Schmid R; Hatletveit AR; Wågbø AM; Sundan A; Skotland T; Sandvig K; Mørch Ý
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156588
[TBL] [Abstract][Full Text] [Related]
20. Design of fluorescently tagged poly(alkyl cyanoacrylate) nanoparticles for human brain endothelial cell imaging.
Brambilla D; Nicolas J; Le Droumaguet B; Andrieux K; Marsaud V; Couraud PO; Couvreur P
Chem Commun (Camb); 2010 Apr; 46(15):2602-4. PubMed ID: 20449321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
